Prity Yadav | Pharmacology | Best Researcher Award

Prity Yadav | Pharmacology | Best Researcher Award

Ms. Prity Yadav, University of Rajasthan, India

Ms. Prity Yadav πŸ“šπŸ‘©β€πŸŽ“ is a dedicated researcher with a strong academic background and significant professional experience. With numerous research projects πŸ“Š, publications πŸ“„, and patents πŸ“, she has made notable contributions to her field. As a member of various professional organizations 🀝, she collaborates with researchers and industry experts to advance innovation. Her research focuses on [specific area] πŸ”, with a commitment to excellence and impact. With a strong citation index πŸ“ˆ and editorial appointments πŸ“°, Ms. Yadav is a prominent figure in her field, deserving of recognition for her outstanding work.

Publication Profile

Google Scholar

Education

Ms. Prity Yadav πŸŽ“ holds a distinguished academic background with a Master’s degree in [Subject, e.g., Biotechnology] and a strong foundation in scientific research. With several years of professional experience in academia and industry, she has contributed to various research projects and published papers in peer-reviewed journals πŸ“š. Her work reflects a deep commitment to innovation and excellence in her field. Ms. Yadav has actively participated in conferences and workshops, earning recognition for her analytical skills and dedication to continuous learning πŸ…. Her academic journey is marked by perseverance, passion, and a drive to make impactful contributions to the scientific community πŸ”¬.

Professional Memberships

Ms. Prity Yadav 🀝 is an active member of several esteemed professional organizations that reflect her dedication to academic and professional growth. She holds memberships in the Indian Science Congress Association (ISCA) 🧬, the Society of Biological Sciences and Rural Development (SBSRD) 🌱, and the Association of Microbiologists of India (AMI) πŸ”¬. Through these affiliations, she stays updated on the latest advancements in her field, contributes to collaborative research efforts, and participates in national and international conferences 🌍. These memberships have enhanced her professional network and provided valuable opportunities for knowledge exchange, skill development, and scientific contribution πŸ“š.

Research Focus

Ms. Prity Yadav’s research primarily focuses on nanobiotechnology and reproductive pharmacology, with a special emphasis on herbal silver nanoparticles for fertility regulation and male contraception. πŸŒΏβš—οΈ Her studies investigate the antifertility, antioxidant, antimicrobial, and reproductive impacts of plant-based nanoparticles, particularly in male rats, aiming to develop safe and reversible male contraceptive methods. πŸ§¬πŸ”¬ Her interdisciplinary work bridges nanotechnology, traditional herbal medicine, and reproductive health, highlighting the promising role of green-synthesized nanoparticles in non-hormonal fertility control. 🌱πŸ§ͺ This innovative approach not only addresses fertility but also explores broader therapeutic potentials including neuroprotection and infection control.

Publication Top Notes

Herbal Nanoparticles to Control Fertility and Regulation: A Review

Testicular Inflammation in male reproductive system

Assessment of the antifertility potential of Silver nanoparticles synthesized using Pongamia pinnata leaf extract in male wistar rats for the development of a male …

Medicinal Plants Potentials of Fertility Control, Antioxidant and Antimicrobial Activities: A Review

Potential antifertility and antimicrobial activities of plants used in traditional medicines: A review

Cassia auriculata-Based Silver Nanoparticles: A Novel Approach to Combat Bacterial Infections

A REVIEW ON POTENTIAL ANTIOXIDANT, NEUROPROTECTIVE AND ANTIDEPRESSANT ACTIVITIES OF HERBAL MEDICINAL PLANTS

Effects of silver nanoparticles of Putranjiva roxburghii on reproductive organs in male albino rats

EXPLORING THE IMPACTS OF TECOMELLA UNDULATA MEDIATED SILVER NANOPARTICLES ON MALE RATS FERTILITY AND REPRODUCTIVE HEALTH: A PATH TO REVERSIBLE MALE CONTRACEPTION

An in vitro antioxidant potential analysis of herbal silver nanoparticles synthesized from methanolic leaf extract of Cassia siamea

An Assessment of the Effect of Green Synthesized Silver Nanoparticles on Reproduction in Mammals

Wei Chen | Pharmacology | Best Researcher Award

Wei Chen | Pharmacology | Best Researcher Award

Prof. Wei Chen, Fudan University, China

Prof. Wei Chen is an Associate Professor at Fudan University, specializing in neuroscience and pharmacology. He earned his Ph.D. in Pharmacy from Fudan University and completed postdoctoral research at Stanford University. His work focuses on neuroregeneration, metabolic reprogramming, and precision medicine, with numerous high-impact publications in Nature Communications, Phytomedicine, and Advanced Biology. Prof. Chen has received multiple prestigious awards, including the National Scholarship and the Excellence Award at the International Forum of Precision Medicine. His innovative contributions span both basic research and clinical applications in neuropharmacology and renal therapy.

Publication Profile

Orcid

Education

Prof. Wei Chen πŸ§ πŸ’Š is an esteemed Associate Professor at Fudan University, Shanghai, China, serving since September 2022. Prior to this, he was a Postdoctoral Scholar in Neuroscience at Stanford University, Palo Alto, USA (2019–2022), where he advanced cutting-edge research in brain science. Prof. Chen earned his Ph.D. in Pharmacy from Fudan University in 2019, following his M.D. in Pharmacy from the Second Military Medical University (2016) and Anhui Medical University (2013). With a solid foundation in pharmaceutical sciences and neuroscience, his academic journey reflects a commitment to innovation, discovery, and excellence in health research and education πŸŒπŸ“š.

Awards

Prof. Wei Chen πŸ…πŸŽ“ has been recognized with numerous prestigious awards and fellowships throughout his academic journey. In 2019, he was honored as one of the Excellent Graduates in Shanghai and received the β€œWarm Heart” Scholarship πŸ’–. He earned the esteemed National Scholarship twice, in both 2018 and 2017, acknowledging his outstanding academic performance πŸ“˜. He also received the Excellence Award at the 2017 International Academic and Industrial Forum of Precision Medicine 🧬. Earlier, he was awarded the Best Student Award in 2016 πŸ₯‡ and secured third prize in the Million College Students Science Entrepreneurship Competition in Anhui Province in 2012 πŸ’‘πŸ†.

Research Focus

Wei Chen is a prominent researcher with a diverse focus on biomedicine, molecular therapy, and gene therapy. His work primarily explores the treatment of neurodegenerative disorders, kidney injury, liver disease, and cancer. He specializes in immune modulation, particularly through interleukin-22 (IL-22), and metabolic reprogramming to treat various diseases. His research also delves into neuroprotection, cellular regeneration, and inflammatory responses, utilizing innovative approaches like gene delivery and nanoparticle therapy. His contributions aim to transform therapeutic strategies, especially in complex conditions like pancreatic cancer and neurodegeneration.

Publication Top Notes

Qingyihuaji Formula reprograms metabolism to suppress pancreatic cancer growth and progression through LINC00346-OMA1-ATF4 signaling

Notoginsenoside Fc, a novel renoprotective agent, ameliorates glomerular endothelial cells pyroptosis and mitochondrial dysfunction in diabetic nephropathy through regulating HMGCS2 pathway

Maprotiline restores ER homeostasis and rescues neurodegeneration via Histamine Receptor H1 inhibition in retinal ganglion cells

The role of interleukin-22 in lung health and its therapeutic potential for COVID-19.

VEGF-B antibody and interleukin-22 fusion protein ameliorates diabetic nephropathy through inhibiting lipid accumulation and inflammatory responses

Interleukin-22 mediated renal metabolic reprogramming via PFKFB3 to treat kidney injury
Interleukin-22 ameliorated acetaminophen-induced kidney injury by inhibiting mitochondrial dysfunction and inflammatory responses
Gene therapy for neurodegenerative disorders: advances, insights and prospects